Dr. Edwin N. Lee of Age Management Medicine interviews Dr Zach Bush
Over the last 10 years there has been an explosion of basic science data that has revealed a link between the intestinal microbiome and systemic disease in the human host. The lack of some species, or the presence of other bacterial species correlates with the occurrence of metabolic diseases, immune dysfunction, and many cancers. This correlation has radically changed the landscape of anti-aging and cancer research, and broadened the potential adjuvant therapies and interventions to prevent and reverse chronic disease in the future. This lecture reveals new insights into direct and indirect mechanisms by which the bacterial biome may mediate systemic disease. The effects of a novel family of redox molecules produced by bacteria have been shown to mediate tight junction barrier systems in the human body, reactive oxygen production from the mitochondria, and balance bacterial flora. What is Age Management Medicine? Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions. About AMMG It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical associations and providers of products and services.